PEG

Bis-aminooxy-PEG3 (Legacy Tebubio ref. 282T14619). Bis-aminooxy-PEG3 is a PEG-based linker for PROTACs that joins two essential ligands, crucial for forming PROTAC molecules [Proteolysis-Targeting Chimeras]. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

Bis-aminooxy-PEG4 (Legacy Tebubio ref. 282T14620). Bis-aminooxy-PEG4 is a PEG-based linker for PROTACs that joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

Bis-PEG1-NHS ester (Legacy Tebubio ref. 282T14627). Bis-PEG1-NHS ester is a non-cleavable 1-unit PEG linker used in antibody-drug conjugation (ADC) to link antibodies with drugs.

Bis-PEG2-acid (Legacy Tebubio ref. 282T14630). Bis-PEG2-acid is a PEG-based linker for PROTACs that connects two essential ligands, facilitating the formation of PROTAC molecules and enabling selective protein degradation through the ubiquitin-proteasome system within cells.

bis-PEG2-endo-BCN (Legacy Tebubio ref. 282T14631). Bis-PEG2-endo-BCN is a two-unit cleavable polyethylene glycol (PEG) linker employed in the synthesis of antibody-drug conjugates (ADCs)[1].

Bis-PEG3-NHS ester (Legacy Tebubio ref. 282T14635). Bis-PEG3-NHS ester is a noncleavable 3-unit PEG linker used in antibody-drug conjugation (ADC).

Bis-PEG4-acid (Legacy Tebubio ref. 282T14638). Bis-PEG4-acid is a PEG PROTAC linker (PROteolysis TArgeting Chimera) used in targeted protein degradation applications.

Bis-PEG4-PFP ester (Legacy Tebubio ref. 282T14640). Bis-PEG4-PFP ester is a PEG-based linker for PROTACs, joining two essential ligands and enabling selective protein degradation through the ubiquitin-proteasome system within cells.

Bis-PEG4-sulfonic acid (Legacy Tebubio ref. 282T14641). Bis-PEG4-sulfonic acid is a PEG-based linker for PROTACs, facilitating the conjugation of essential ligands critical for PROTAC molecule formation. It enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.